Peter S. Chan

1.8k total citations
53 papers, 1.5k citations indexed

About

Peter S. Chan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Peter S. Chan has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Organic Chemistry. Recurrent topics in Peter S. Chan's work include Electrolyte and hormonal disorders (8 papers), Neuroendocrine regulation and behavior (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Peter S. Chan is often cited by papers focused on Electrolyte and hormonal disorders (8 papers), Neuroendocrine regulation and behavior (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Peter S. Chan collaborates with scholars based in United States, Hong Kong and Canada. Peter S. Chan's co-authors include Franky Leung Chan, H.L. Choi, Zhen‐Yu Chen, Yü Huang, J. Donald Albright, Ka‐Fai To, Wai Shan Wong, Kwok Wai Lo, Ho Yuen Cheung and Fernand M.M. Lai and has published in prestigious journals such as Analytical Biochemistry, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Peter S. Chan

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter S. Chan United States 19 690 342 296 280 189 53 1.5k
Wolfram Steinke Germany 15 591 0.9× 134 0.4× 159 0.5× 289 1.0× 138 0.7× 31 1.7k
H Hess United States 20 304 0.4× 331 1.0× 493 1.7× 312 1.1× 62 0.3× 62 1.3k
Keiji Kubo Japan 19 609 0.9× 553 1.6× 268 0.9× 116 0.4× 145 0.8× 49 1.9k
David Aharony United States 26 675 1.0× 307 0.9× 66 0.2× 224 0.8× 419 2.2× 63 1.8k
Terrance D. Barrett United States 17 557 0.8× 97 0.3× 403 1.4× 170 0.6× 207 1.1× 43 1.6k
Susan Butler United States 9 653 0.9× 211 0.6× 704 2.4× 63 0.2× 96 0.5× 16 2.7k
Deirdre M. B. Hickey United Kingdom 20 516 0.7× 387 1.1× 382 1.3× 31 0.1× 103 0.5× 40 1.3k
Junko Nakao Japan 19 323 0.5× 182 0.5× 139 0.5× 59 0.2× 327 1.7× 30 1.3k
Sam Rebello United States 21 215 0.3× 56 0.2× 133 0.4× 60 0.2× 76 0.4× 58 1.1k
R Gryglewski Poland 7 372 0.5× 72 0.2× 132 0.4× 111 0.4× 906 4.8× 18 1.6k

Countries citing papers authored by Peter S. Chan

Since Specialization
Citations

This map shows the geographic impact of Peter S. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Chan more than expected).

Fields of papers citing papers by Peter S. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Chan. The network helps show where Peter S. Chan may publish in the future.

Co-authorship network of co-authors of Peter S. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter S. Chan. A scholar is included among the top collaborators of Peter S. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter S. Chan. Peter S. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Guangfu, Franky Leung Chan, Xu Zhang, & Peter S. Chan. (2009). Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(2). 220–226. 1 indexed citations
2.
Failli, Amedeo, Robert J. Steffan, David Williams, et al.. (2005). Pyridobenzodiazepines: A novel class of orally active, vasopressin V2 receptor selective agonists. Bioorganic & Medicinal Chemistry Letters. 16(4). 954–959. 37 indexed citations
3.
Venkatesan, Aranapakam M., et al.. (2005). (4-Substituted-phenyl)-(5H-10,11-dihydro-pyrrolo [2,1-c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators. Bioorganic & Medicinal Chemistry Letters. 15(22). 5003–5006. 9 indexed citations
4.
5.
Sum, Fuk‐Wah, John P. Dusza, Efren Delos Santos, et al.. (2003). Structure–activity study of novel tricyclic benzazepine arginine vasopressin antagonists. Bioorganic & Medicinal Chemistry Letters. 13(13). 2195–2198. 34 indexed citations
6.
Chan, Michael W.Y., Nelson L.S. Tang, Kwok Wai Lo, et al.. (2003). Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. International Journal of Cancer. 104(5). 611–616. 94 indexed citations
7.
8.
Lau, Harry Cheuk-Hay, Xiaoming Zhu, Peter C. K. Leung, et al.. (2001). Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates. International Journal of Oncology. 19(6). 1193–201. 13 indexed citations
9.
Lee, Danny W.H., et al.. (2000). Soft-tissue case 31. Presentation. Canadian Journal of Surgery. 43(1). 14–14. 1 indexed citations
10.
Albright, J. Donald, et al.. (2000). The synthesis and vasopressin (AVP) antagonist activity of a novel series of n-aroyl-2,4,5,6-tetrahydropyrazolo [3,4-d]thieno[3,2-b]azepines. Bioorganic & Medicinal Chemistry Letters. 10(8). 695–698. 16 indexed citations
11.
Kwong, Joseph, Jim W. Xuan, H.L. Choi, Peter S. Chan, & Franky Leung Chan. (2000). PSP94 (or ?-microseminoprotein) is a secretory protein specifically expressed and synthesized in the lateral lobe of the rat prostate. The Prostate. 42(3). 219–229. 18 indexed citations
12.
Albright, J. Donald, et al.. (1999). 4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(13). 1733–1736. 9 indexed citations
13.
Hawkins, B. R., Peter S. Chan, Ignatius K.P. Cheng, et al.. (1997). Highly successful long‐term outcome of kidney transplantation in Chinese recipients: an enhancing race effect?. Clinical Transplantation. 11(3). 178–184. 7 indexed citations
14.
Lai, Fernand Mac–Moune, et al.. (1995). Aggressive Fibromatosis of the Spermatic Cord:A Typical Lesion in a “New” Location. American Journal of Clinical Pathology. 104(4). 403–407. 16 indexed citations
15.
Meyer, W.E., et al.. (1989). 5-(1-Piperazinyl)-1H-1,2,4-triazol-3-amines as antihypertensive agents. Journal of Medicinal Chemistry. 32(3). 593–597. 12 indexed citations
16.
Kreel, L, et al.. (1989). The Radiological Diagnosis and Management of Angiomylipoma of Tuberous Sclerosis. Australasian Radiology. 33(2). 176–181. 2 indexed citations
17.
18.
Wright, William B., et al.. (1986). Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides. Journal of Medicinal Chemistry. 29(4). 523–530. 47 indexed citations
19.
Bentley, P G, Vijay V. Kakkar, Michael Scully, et al.. (1980). An objective study of alternative methods of heparin administration. Thrombosis Research. 18(1-2). 177–187. 94 indexed citations
20.
Barlow, Grant H., et al.. (1979). Biochemical comparison of intermittent streptokinase and intermittent streptokinase plasminogen therapy. Thrombosis Research. 15(1-2). 135–142. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfram Steinke Breakdown of academic impact, for papers by H Hess Breakdown of academic impact, for papers by Keiji Kubo Breakdown of academic impact, for papers by David Aharony Breakdown of academic impact, for papers by Terrance D. Barrett Breakdown of academic impact, for papers by Susan Butler Breakdown of academic impact, for papers by Deirdre M. B. Hickey Breakdown of academic impact, for papers by Junko Nakao Breakdown of academic impact, for papers by Sam Rebello Breakdown of academic impact, for papers by R Gryglewski
Rankless by CCL
2026